Charlotte BevanAcademic
Professor of cancer biology at Imperial College London
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“an advance in using immunotherapy for prostate cancer was potentially very exciting, opening up a new class of drug. But, she added, it was important studies were carried out with patients of different ethnicities, as there were disparities in prostate cancer outcomes.”
Professor of cancer biology at Imperial College London · Cancer · 27 Aug 2026 · Researchers praise ‘stunning’ results of new prostate cancer treatment ↗
Source references
- Researchers praise ‘stunning’ results of new prostate cancer treatmenttheguardian.com · 27 Aug 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.